Form 4: Foghorn Therapeutics CEO Adrian Gottschalk Awarded Stock Options

Foghorn Therapeutics CEO Adrian Gottschalk was granted options to purchase 400,000 shares of common stock on January 22, 2025.

Summary

• Adrian Gottschalk, CEO of Foghorn Therapeutics Inc., was granted a stock option to purchase 400,000 shares of the company's common stock.
• The transaction occurred on January 22, 2025.
• The exercise price of the option is $4.37 per share.
• The option vests as to 25% of the underlying shares on January 22, 2026, and then at a rate of 6.25% per quarter thereafter.
• The option expires on January 21, 2035.
• A power of attorney was executed on January 17, 2025, granting certain individuals the authority to file SEC forms on Gottschalk's behalf.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options is a standard practice and generally viewed as a positive incentive for management.

Positives

• The granting of stock options to the CEO can be seen as an incentive to align his interests with those of the shareholders.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the options.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders by incentivizing them to increase the company's stock value.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the biotech industry.
• Companies like Amgen, Gilead, and Biogen also utilize stock options as part of their executive compensation strategy.
• The vesting schedule and exercise price are typical for such grants, designed to incentivize long-term performance.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive incentive for the CEO to increase shareholder value.
• Employees may see this as a sign of confidence in the company's future.

Key Dates